December 19, 2014 5:14 AM ET

Biotechnology

Company Overview of Maxygen, Inc.

Executive Profile

James R. Sulat MBA

Consultant, Maxygen, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 9 different industries.

See Board Relationships
64$774,513
As of Fiscal Year 2012

Background

Mr. James R. Sulat, also known as Jim, MBA, has been a Consultant of Maxygen, Inc. since June 30, 2013. Mr. Sulat served as Vice President of Finance and MIS at D.B. Hess, Inc. Mr. Sulat served as the Chief Executive Officer and Chief Financial Officer of Maxygen Inc., from October 1, 2009 to June 30, 2013 and served as its Principal Accounting Officer until June 30, 2013. He served as an Interim Chief Financial Officer for Moore Wallace Inc. since February 9, 2004. ...

Corporate Headquarters

411 Borel Avenue
San Mateo, California 94402

United States

Phone: 650-241-2292
Fax: 650-257-5892

Board Members Memberships

1994-Present
Director, Chairman of Audit Committee and Member of Corporate Governance Committee
1997-Present
Director
2003-2013
Consultant
2005-N/A
Director
2008-Present
Chairman, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2009-N/A
Former Director
2009-Present
Member of Board of Managers
2014-Present
Director, Member of Transaction Committee and Member of Audit Committee

Education

BS
Yale University
MS
Stanford Graduate School of Business
MBA
Stanford Graduate School of Business

Other Affiliations

Annual Compensation

Salary$536,259
Total Annual Compensation$536,259

Stocks Options

All Other Compensation$14,814
Exercisable Options$412,500
Unexercisable Options$75,000
Total Number of Options$487,500

Total Compensation

Total Annual Cash Compensation$774,513
Total Short Term Compensation$536,259
Other Long Term Compensation$14,814
Total Calculated Compensation$774,513
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Maxygen, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.